Medicare Enrolled

Dr. Rama Reddy, MD

Optician · Belleville, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5 FRANKLIN AVE, Belleville, NJ 07109
9737591111
In practice since 2006 (19 years)
NPI: 1386724672 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reddy

Dr. Rama Reddy is an optician specialist in Belleville, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 2,691 Medicare services across 882 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reddy received a total of $10,105 from 42 pharmaceutical and/or device companies across 658 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in NJ $10,105 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,691
Medicare services
Top 26% in NJ for optician
882
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~142 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 905 $0 $0
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
580 $98 $203
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
432 $3 $19
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
308 $98 $489
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
103 $77 $150
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
57 $78 $105
Diabetes self-management training, individual
Individualized education and training for managing diabetes, billed per 30-minute session.
53 $44 $200
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
49 $12 $68
Body fluid smear cell examination
A laboratory test where a sample of body fluid is spread on a slide and examined under a microscope to check for abnormal cells.
38 $63 $186
Cell examination of specimen, concentration technique
A laboratory test that uses a concentration technique to examine cells from a specimen.
38 $60 $183
Fine needle aspirate evaluation and report
A pathologist examines cells collected via a fine needle aspiration and provides a written interpretation and report of the findings.
35 $146 $293
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
35 $64 $184
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
29 $112 $762
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $130 $260
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,105
Total received (2018-2024)
Avg $1,444/year across 7 years
Top 10% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
658
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,092 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$582
2023
$796
2022
$1,614
2021
$1,737
2020
$1,372
2019
$1,395
2018
$2,609

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$144
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$133
Lilly USA, LLC
$62
ABBVIE INC.
$45
AstraZeneca Pharmaceuticals LP
$45
Novo Nordisk Inc
$44
Amgen Inc.
$34
Abbott Laboratories
$25
Corcept Therapeutics
$19
RECORDATI_RARE_DISEASES_INC.
$16
Radius Health, Inc.
$14
Top 3 companies account for 58.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,372
Amgen Inc.
$1,247
Lilly USA, LLC
$1,125
Novo Nordisk Inc
$902
Boehringer Ingelheim Pharmaceuticals, Inc.
$778
Janssen Pharmaceuticals, Inc
$557
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$508
SANOFI-AVENTIS U.S. LLC
$441
Abbott Laboratories
$370
Mannkind Corporation
$364
Merck Sharp & Dohme Corporation
$314
MannKind Corporation
$293
Novartis Pharmaceuticals Corporation
$209
Insulet Corporation
$191
Radius Health, Inc.
$181
Kowa Pharmaceuticals America, Inc.
$142
Valeritas, Inc.
$132
Endo Pharmaceuticals Inc.
$114
Zealand Pharma US, Inc.
$105
Becton, Dickinson and Company
$59
ABBVIE INC.
$58
AbbVie Inc.
$57
Amneal Pharmaceuticals LLC
$55
Medtronic, Inc.
$54
Regeneron Healthcare Solutions, Inc.
$54
CeQur Corporation
$51
IBSA Pharma Inc.
$41
Shire North American Group Inc
$40
Xeris Pharmaceuticals, Inc.
$35
DEXCOM, INC.
$32
RECORDATI_RARE_DISEASES_INC.
$31
Dexcom, Inc.
$30
Gemini Laboratories, LLC
$27
Corcept Therapeutics
$19
PFIZER INC.
$18
Alexion Pharmaceuticals, Inc.
$16
NOVARTIS PHARMACEUTICALS CORPORATION
$16
AbbVie, Inc.
$15
Amryt Pharma Holdings Ltd
$14
LifeScan, Inc.
$13
Aytu BioScience, Inc
$13
Medtronic MiniMed, Inc.
$11
Top 3 companies account for 37.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · CYCLOSET · CeQur Simplicity · Corlanor · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKAMET · INVOKANA · InPen · JANUVIA · JARDIANCE · Korlym · LEQVIO · Livalo · MOUNJARO · MYALEPT · Minimed 670G System · NATPARA · Natesto · Omnipod · OneTouch · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STRENSIQ · SYNTHROID · Synthroid · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Victoza · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZEGALOGUE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for optician in NJ.

Looking for an optician specialist in Belleville?
Compare opticians in the Belleville area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
13,832
Per 100K population
1619.4
County median income
$76,712
Nearest hospital
CLARA MAASS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Reddy is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NJ), with low-engagement industry engagement in the top 10% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Reddy experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Reddy performed 905 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $10,105 from 42 companies across 658 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other opticians in Belleville?
Dr. Reddy's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →